RAYMOND JAMES & ASSOCIATES - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$976,628
-48.0%
19,447
-34.6%
0.00%
-50.0%
Q2 2023$1,879,252
+176.7%
29,735
+97.0%
0.00%
+100.0%
Q1 2023$679,169
+8.6%
15,096
+5.7%
0.00%0.0%
Q4 2022$625,475
-69.8%
14,277
-54.6%
0.00%
-50.0%
Q3 2022$2,071,000
+41.9%
31,433
+8.8%
0.00%
+100.0%
Q2 2022$1,459,000
-27.6%
28,882
-8.5%
0.00%
-50.0%
Q1 2022$2,016,000
-29.3%
31,565
+18.6%
0.00%0.0%
Q4 2021$2,851,000
+38.0%
26,620
+32.4%
0.00%0.0%
Q3 2021$2,066,000
+30.4%
20,100
+11.6%
0.00%
+100.0%
Q2 2021$1,584,000
-10.7%
18,013
-1.3%
0.00%
-50.0%
Q1 2021$1,774,000
-53.7%
18,247
-46.6%
0.00%
-50.0%
Q4 2020$3,835,000
+8.9%
34,191
-10.0%
0.00%0.0%
Q3 2020$3,521,000
+41.3%
37,978
+18.9%
0.00%
+33.3%
Q2 2020$2,492,000
+44.1%
31,953
+8.1%
0.00%0.0%
Q1 2020$1,729,000
-11.2%
29,562
+21.6%
0.00%
+50.0%
Q4 2019$1,948,000
+202.5%
24,314
+177.3%
0.00%
+100.0%
Q3 2019$644,000
-14.9%
8,768
+9.2%
0.00%0.0%
Q2 2019$757,000
-5.7%
8,027
-20.0%
0.00%0.0%
Q1 2019$803,000
+39.7%
10,029
-6.0%
0.00%0.0%
Q4 2018$575,000
-31.4%
10,667
-0.6%
0.00%0.0%
Q3 2018$838,000
+258.1%
10,736
+320.0%
0.00%
Q1 2018$234,000
+3.1%
2,556
-14.9%
0.00%
Q4 2017$227,000
+3.7%
3,004
-4.2%
0.00%
Q3 2017$219,0003,1370.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders